Articles From: Advantest to Exhibit at Flash Memory Summit 2014 in Santa Clara Convention Center August 6-7, 2014 to Advisory: RAI celebrates 10th anniversary


http://media.marketwire.com/attachments/201103/23230_Advant.gif http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1134790&ProfileId=051205&sourceType=1 SAN JOSE, CA --
Sign-up for Advantest to Exhibit at Flash Memory Summit 2014 in Santa Clara Convention Center August 6-7, 2014 investment picks
http://media.marketwire.com/attachments/201407/77799_logo.jpg http://media.marketwire.com/attachments/201103/23230_Advant.gif http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1133828&ProfileId=051205&sourceType=1 TOKYO, JAPAN --
Sign-up for Advantest's Global Deployment of New MPT3000 Testers for Solid-State Drives Commences With Multiple Orders investment picks
PRINCETON, N.J., July 22, 2014 (GLOBE NEWSWIRE) -- Advaxis, Inc. (Nasdaq:ADXS) , a clinical-stage biotechnology company developing cancer immunotherapies, has entered into a clinical trial collaboration with MedImmune, the global biologics research and development arm of AstraZeneca.
Sign-up for Advaxis and MedImmune Partner on Immuno-Oncology Combination Clinical Trial investment picks
PRINCETON, N.J., July 29, 2014 (GLOBE NEWSWIRE) -- Advaxis, Inc. (Nasdaq:ADXS) , a clinical-stage biotechnology company developing cancer immunotherapies, and the University of Pennsylvania signed an amendment to restructure their 2002 Exclusive License, which relates to Advaxis's proprietary Listeria monocytogenes Lm -LLO cancer immunotherapy technology.
Sign-up for Advaxis and the University of Pennsylvania Restructure Their Exclusive License Agreement investment picks
PRINCETON, N.J., July 2, 2014 (GLOBE NEWSWIRE) -- Advaxis, Inc. (Nasdaq:ADXS) , a biotechnology company developing cancer immunotherapies, announced that a product license from the United States Department of Agriculture (USDA) has been filed for ADXS-cHER2, its proprietary Her2/neu-directed cancer immunotherapy for the treatment of canine osteosarcoma and other HER2-overexpressing cancers.
Sign-up for Advaxis Announces Filing for USDA Product License investment picks
PRINCETON, N.J., June 16, 2014 (GLOBE NEWSWIRE) -- Advaxis, Inc. (Nasdaq:ADXS) , a clinical-stage biotechnology company developing cancer immunotherapies, announced that the Georgia Regents University (GRU) Cancer Center has received Institutional Review Board (IRB) approval to initiate a Phase 1/2 trial evaluating higher doses and repeat cycles of ADXS-HPV in patients with recurrent cervical cancer.
Sign-up for Advaxis Evaluates Higher Dose and Repeat Cycles of ADXS-HPV in Phase 1/2 Cervical Cancer Trial investment picks
PRINCETON, N.J., July 28, 2014 (GLOBE NEWSWIRE) -- Advaxis, Inc. (Nasdaq:ADXS) , a biotechnology company developing the next generation of cancer immunotherapies, announced that it has received a notice of allowance from the Japan Patent Office for a patent application related to the Advaxis proprietary Lm -LLO cancer immunotherapy platform technology.
Sign-up for Advaxis Receives Notice of Allowance for Cancer Immunotherapies Patent in Japan investment picks
PRINCETON, N.J., June 23, 2014 (GLOBE NEWSWIRE) -- Advaxis, Inc .
Sign-up for Advaxis Receives Notice of Allowance From U.S. Patent Office for Two Patent Applications With Multiple Claims Covering Its Cancer Immunotherapy ADXS-cHER2 investment picks
PRINCETON, N.J., June 25, 2014 (GLOBE NEWSWIRE) -- Advaxis, Inc. (Nasdaq:ADXS) , a clinical-stage biotechnology company developing cancer immunotherapies, today announced that the Company will be added to the Russell Microcap Index when Russell Investments reconstitutes its comprehensive set of U.S. and global equity indices on June 27.
Sign-up for Advaxis to be Added to Russell Microcap Index investment picks
PRINCETON, N.J., Sept.
Sign-up for Advaxis to Present at Upcoming Investor Conferences investment picks
PRINCETON, N.J., June 30, 2014 (GLOBE NEWSWIRE) -- Advaxis, Inc. (Nasdaq:ADXS) , a biotechnology company developing cancer immunotherapies, announced that ADXS-cHER2, its proprietary immunotherapy, was featured on CBS New York in a segment focused on encouraging data from a second study combining ADXS-cHER2 with radiation therapy to treat companion dogs with osteosarcoma (bone cancer). The reporters commented that treatment prolongs the lives of dogs with bone cancer and could one day help people with cancer.
Sign-up for Advaxis's Cancer Immunotherapy Featured on CBS News investment picks
http://media.marketwire.com/attachments/201405/75182_ADVENT.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1142630&ProfileId=051205&sourceType=1 SAN FRANCISCO, CA --
Sign-up for Advent Announces Next Generation of the Black Diamond Wealth Management Platform: Designed to Elevate the Investor Experience and Enhance Firm Level Productivity investment picks
http://media.marketwire.com/attachments/201405/75182_ADVENT.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1142629&ProfileId=051205&sourceType=1 LAS VEGAS, NV and SAN FRANCISCO, CA --
Sign-up for Advent Showcases Product Upgrades Across Its Solution Suite at AdventConnect 2014 investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1133748&ProfileId=051205&sourceType=1 SAN FRANCISCO, CA --
Sign-up for Advent Software Reports Second Quarter 2014 Results investment picks
http://media.marketwire.com/attachments/201405/75182_ADVENT.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1140384&ProfileId=051205&sourceType=1 SAN FRANCISCO, CA and LONDON, UNITED KINGDOM --
Sign-up for Advent Wins "Best Client Reporting System" at Systems in the City Awards 2014 investment picks
More RIAs Are Leveraging Portfolio Management Solution to Engage Their Clients Online and Differentiate From Robo-Advisors CHICAGO , Aug.
Sign-up for Advisor View™ by Envestnet | Tamarac™ Is One of the Fastest Growing Portfolio Management and Client Engagement Applications for RIAs investment picks
2014/7/17
MONTREAL , July 17, 2014 /PRNewswire/ - Boralex Inc. (" Boralex " or the " Corporation ") announces that the release of the 2014 second quarter financial results will take place on August 6, 2014 .
Sign-up for Advisory - Boralex - Release of the 2014 Second Quarter Financial Results investment picks
Pfizer Inc. (NYSE:PFE) today announced that the Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) voted to recommend Prevnar 13 ® (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM 197 Protein])PCV13) for routine use to help protect adults aged 65 years and older against pneumococcal disease, which includes pneumonia caused by the 13 pneumococcal serotypes included in the vaccine.
Sign-up for Advisory Committee on Immunization Practices Votes to Recommend Pfizer’s Prevnar 13® Vaccine in Adults Aged 65 Years and Older investment picks
WINSTON-SALEM, N.C. , Sept.
Sign-up for Advisory: RAI announces establishment of executive stock trading plans investment picks
WINSTON-SALEM, N.C. , July 15, 2014 /PRNewswire/ -- Reynolds American Inc. (NYSE: RAI) has announced the following: "RAI to host 2Q14 earnings conference call on July 29 ." Go to RAI's website, www.reynoldsamerican.com , to read the full release.
Sign-up for Advisory: RAI to host 2Q14 earnings conference call investment picks
WINSTON-SALEM, N.C. , Aug.
Sign-up for Advisory: RAI to webcast CEO's participation at Barclays Back-To-School Consumer Conference investment picks
WINSTON-SALEM, N.C. , July 18, 2014 /PRNewswire/ -- The board of directors of Reynolds American Inc. (NYSE: RAI) and the company's management team today expressed condolences to the family of Sir Nicholas Scheele .
Sign-up for Advisory: Reynolds American expresses condolences to the family of Sir Nicholas Scheele investment picks
WINSTON-SALEM, N.C. , July 17, 2014 /PRNewswire/ -- Reynolds American Inc. (NYSE: RAI) has issued the following press release: "RAI board declares quarterly cash dividend." For full details, read the release on RAI's website, www.reynoldsamerican.com .
Sign-up for Advisory: RAI board declares quarterly cash dividend investment picks
WINSTON-SALEM, N.C. , Aug.
Sign-up for Advisory: RAI celebrates 10th anniversary investment picks
Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Advantest to Exhibit at Flash Memory Summit 2014 in Santa Clara Convention Center August 6-7, 2014 to Advisory: RAI celebrates 10th anniversary
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices